Cardiac Monitoring Market - Top Players and Business Intelligence
According to the new market research report cardiac monitoring market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025.
The
growth of this market is driven by the increasing prevalence of
cardiovascular diseases; availability of reimbursement for CM & CRM
devices; launch of innovative products by market players; increasing
investments, funds, and grants for research on CM & CRM devices; and
the growing preference for wearable cardiac devices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55
The
major players operating in this Cardiac Monitoring Market are Medtronic
(Ireland), Boston Scientific (US), Abbott Laboratories (US), GE
Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips
(Netherlands), Asahi Kasei Corporation (Japan), ACS Diagnostics (US),
MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon
Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL
Medical Technologies (India), Shenzhen Mindray Bio-Medical Electronics
(China), Lepu Medical Technology (China), Shree Pacetronix (India),
OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy),
Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH
(Germany), and Progetti Srl (Italy).
Medtronic (Ireland)
Medtronic
is one of the leading companies in the cardiac monitoring and cardiac
rhythm management devices market. In order to maintain its position,
Medtronic continuously focuses on gaining approvals for its advanced
products in this market. Between 2017 and 2020, the company received
approval for various cardiac devices, such as pacemakers and
defibrillators. Medtronic operates in more than 160 countries across
North America, Western Europe, Asia, and Latin America.
Abbott Laboratories (US)
Abbott
has a strong foothold in the cardiac monitoring devices market. In
2017, Abbott entered the pacemakers market with the acquisition of St.
Jude Medical (US). Abbott received approval for its magnetic resonance
(MR)-conditional labeling for both the Assurity MRI pacemaker and the
Tendril MRI pacing lead. The Assurity MRI pacemaker is the world’s
smallest and longest-lasting wireless MRI-compatible pacemaker, which
gives added advantage to the company, thus helping the company in
maintaining its leading position in the market.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55
On
the basis of region, the Cardiac Monitoring Market is segmented into
North America, Europe, Asia Pacific, and Rest of the World. In 2019,
North America commanded the largest share of the market. The large share
of this market segment can be attributed to the increasing incidence of
CVD, increasing healthcare expenditure, growing disposable income,
growing healthcare awareness, and the availability of technologically
advanced devices in the region.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment